MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0000028
Altoven Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹80.39 Lakh
▲ 494% YoY
Net loss · FY 2024
₹1.23 Cr
Net margin -153.5%
EBITDA · FY 2024
-₹91.74 Lakh
EBITDA margin -114.1%
Authorised capital
₹1.2 Cr
Registered with MCA
Paid-up capital
₹1.2 Cr
Issued & subscribed
Open charges
₹32.17 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
5
As per MCA filings
About Altoven Pharmaceuticals Private Limited
Data last updated:
Altoven Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24110TN2020PTC135338. Its GSTIN is 33AATCA4713C1ZY (Tamil Nadu).
The company has an authorised share capital of ₹1.2 Cr and a paid-up capital of ₹1.2 Cr. It is led by directors including Rajagopal Pradeepan and Natarajan Ilangovan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.P.K.19 Phase V Industrial Estate Ekkaduthangal, Chennai, Tamil Nadu, India – 600032.
As per the financials filed for FY 2024, the company reported a revenue of ₹80.39 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.23 Cr (net margin -153.5%) and EBITDA of -₹91.74 Lakh (EBITDA margin -114.1%).
As per MCA filings, the company has open charges of ₹32.17 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
Altoven Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0000028). For more details, the company can be reached via its website altovenpharma.com.
Company details
CIN U24110TN2020PTC135338
Registration Number 135338
Incorporation Date 15 May 2020
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0000028
Recognitions & Rankings of Altoven Pharmaceuticals
Contact details
Altoven Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is altovenpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo.P.K.19 Phase V Industrial Estate Ekkaduthangal, Chennai, Tamil Nadu, India – 600032
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Altoven Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Altoven Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Altoven Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Altoven Pharmaceuticals Private Limited, buy the company report.
Financials of Altoven Pharmaceuticals Private Limited
FY 2024 filings availableAltoven Pharmaceuticals Private Limited reported revenue of ₹80.39 Lakh (up 494% YoY) for FY 2024.
Revenue · FY 2024
₹80.39 Lakh ▲ 494%
Net loss · FY 2024
₹1.23 Cr margin -153.5%
EBITDA · FY 2024
-₹91.74 Lakh margin -114.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 494%
EBITDA CAGR growth
1 year
▼ 31%
3 years · compounded
▼ 74%
Revenue rose 494% in the latest year. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹91.74 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.23 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -114.1% | |||
| Net Profit Margin | -153.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Altoven Pharmaceuticals Private Limited, buy the company report.
Board of directors of Altoven Pharmaceuticals Private Limited
Altoven Pharmaceuticals has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajagopal Pradeepan Also directs: Ruotae Heat Hour Private Limited | Director | 15 May 2020 | 6 Years 5 Months | Current |
| Natarajan Ilangovan | Director | 10 Dec 2021 | 4 Years 10 Months | Current |
| Nehrudassan Rajamani Also directs: Cassel Research Laboratories Private Limited | Director | 09 Apr 2022 | 4 Years 6 Months | Current |
| Murugan Naveen Sean | Director | 09 Apr 2022 | 4 Years 6 Months | Current |
| Abinesh Nadimuthu | Additional Director | 27 May 2025 | 1 Years 4 Months | Current |
Auditor
Altoven Pharmaceuticals Private Limited is audited by ALBERT KARUNAKARAN L for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ALBERT KARUNAKARAN L | FY 2023 | 216635 |
Shareholding
The shareholding of Altoven Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Altoven Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹32.17 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Feb 2024 | 100874646 | Others | ₹32.17 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Altoven Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Total cases
2
Filed against the company
2
Pending
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jaipur Metro II, Rajasthan | Court case (Complaint) | Filed against the company by Ugro Capital | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by Anu Pharma Through Its Sole Proprietor Mr Vaibhav D Shah | Pending |
To see the full case history of Altoven Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Altoven Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Altoven Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
Active EPFO establishments
1
GST
Altoven Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AATCA4713C1ZY | Tamil Nadu | Active | 06 Nov 2020 |
To see the full GST registrations and return filing status of Altoven Pharmaceuticals Private Limited, buy the company report.
Recent activity
Altoven Pharmaceuticals Private Limited has 15 board changes on record since 2020: 10 appointments and 5 cessations. The latest: Abinesh Nadimuthu was appointed as Additional Director on 27 May 2025.
Appointed
Abinesh Nadimuthu was appointed as Additional Director.
Ceased
Lakshmanan Rajamani ceased to be Director.
Ceased
Manian Venkatesan ceased to be Director.
Ceased
Periyaiah Ganesan ceased to be Director.
Ceased
Prabakaran Sankaralingam ceased to be Director.
AGM
Altoven Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Altoven Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Charges
A charge with Others amounted to Rs. 0.32 Cr with Charge ID 100874646 was registered on 28 Feb 2024.
Appointed
Lakshmanan Rajamani was appointed as Director.
Appointed
Manian Venkatesan was appointed as Director.
Appointed
Murugan Naveen Sean was appointed as Director.
Appointed
Nehrudassan Rajamani was appointed as Director.
7 earlier events are in the company report.
Frequently asked questions
Altoven Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 May 2020 (6+ years old) and is registered under CIN U24110TN2020PTC135338.
Altoven Pharmaceuticals has 5 current directors:
- Rajagopal Pradeepan - Director
- Natarajan Ilangovan - Director
- Nehrudassan Rajamani - Director
- Murugan Naveen Sean - Director
- Abinesh Nadimuthu - Additional Director
The latest financial statements of Altoven Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Altoven Pharmaceuticals is 33AATCA4713C1ZY, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Altoven Pharmaceuticals is U24110TN2020PTC135338. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Altoven Pharmaceuticals has 2 court cases on record: 2 filed against it. 2 are pending.
Altoven Pharmaceuticals was incorporated on 15 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chennai.
Abinesh Nadimuthu was appointed as Additional Director on 27 May 2025. Lakshmanan Rajamani ceased to be Director on 03 May 2025. Manian Venkatesan ceased to be Director on 03 May 2025. Altoven Pharmaceuticals has 15 board changes on record in total.
Yes, Altoven Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0000028).
Altoven Pharmaceuticals can be reached through the website altovenpharma.com. Its registered office is in Chennai, Tamil Nadu, India.